MIST short interest
Milestone Pharmaceuticals Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 19,009,468 |
|---|---|
| Change vs prior report | 647,785 (+3.5%) |
| Change over six months | +124.9% |
| Days to cover | 15.98 (sector: 3.78) |
| Average daily volume | 1,189,684 |
| Rank in Healthcare | #31 of 922 by days to cover |
MIST short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 19,009,468 | +3.5% | 15.98 | 1,189,684 |
| 2026-09-15 | 18,361,683 | +5.8% | 10.59 | 1,733,080 |
| 2026-08-31 | 17,362,761 | +4.4% | 11.34 | 1,530,579 |
| 2026-08-14 | 16,636,852 | +6.1% | 9.40 | 1,769,774 |
| 2026-07-31 | 15,685,890 | +7.5% | 12.71 | 1,234,112 |
| 2026-07-15 | 14,584,446 | +15.8% | 13.59 | 1,073,499 |
| 2026-06-30 | 12,597,709 | +18.8% | 7.49 | 1,681,152 |
| 2026-06-15 | 10,604,847 | +15.4% | 8.69 | 1,220,711 |
| 2026-05-29 | 9,186,849 | +22.8% | 7.85 | 1,169,612 |
| 2026-05-15 | 7,484,287 | -4.2% | 4.27 | 1,754,038 |
| 2026-04-30 | 7,809,686 | -24.4% | 5.97 | 1,309,049 |
| 2026-04-15 | 10,325,577 | +22.1% | 2.80 | 3,686,839 |
| 2026-03-31 | 8,453,485 | -3.5% | 3.20 | 2,643,670 |
| 2026-03-13 | 8,758,410 | +4.0% | 6.76 | 1,294,910 |
| 2026-02-27 | 8,424,060 | +12.7% | 6.44 | 1,307,442 |
| 2026-02-13 | 7,474,168 | -22.1% | 3.63 | 2,061,707 |
| 2026-01-30 | 9,597,134 | +2.2% | 4.42 | 2,173,372 |
| 2026-01-15 | 9,389,788 | +13.8% | 2.44 | 3,848,434 |
| 2025-12-31 | 8,250,257 | +0.3% | 1.30 | 6,333,777 |
| 2025-12-15 | 8,222,765 | +11.3% | 1.00 | 12,175,867 |
| 2025-11-28 | 7,389,406 | +49.2% | 1.75 | 4,214,477 |
| 2025-11-14 | 4,953,316 | +8.7% | 2.59 | 1,914,637 |
| 2025-10-31 | 4,556,371 | -11.9% | 3.14 | 1,451,499 |
| 2025-10-15 | 5,173,005 | +2.9% | 3.46 | 1,494,820 |
| 2025-09-30 | 5,029,319 | -14.9% | 5.63 | 893,101 |
import finzdata as yf
yf.Ticker("MIST").short_interest # every report since 2017
yf.Client().short_interest(["MIST"], start="2018-01-01")Healthcare short interest · MIST price history · Who owns MIST · All short interest